Description
Testosterone Enanthate — Pharmtech, 250 mg. Week-long ester pharmacology means one injection per week is usually sufficient for stable plasma levels; two injections split the dose for tighter control. A foundation compound rather than a standalone tool — pair with orals, nandrolones, or trenbolones depending on cycle goal.
Key Benefits
- The textbook cycle base — more published research than any other AAS
- Seven-day ester allows twice-weekly or weekly injections
- Predictable serum curves — dose → expected plasma level is linear
- Aromatises — full oestrogenic spectrum requires AI management
- Foundation for nearly every stack: mass, cutting, recomp, bridge
- Each unit dosed at 250 mg — see Recommended Dosage below for protocol-specific intake
Recommended Dosage
Research dosing: TRT 100–200 mg/week; first cycle 400–500 mg/week; intermediate 500–600 mg/week; advanced 700+ mg/week. Above 800 mg/week diminishing anabolic returns with sharply rising sides. Split across 2 injections (Mon/Thu) for stable plasma.
How It Works
Testosterone esterified to enanthoic acid. Plasma esterases hydrolyse the bond, releasing free testosterone that activates the AR across muscle, bone, and CNS. Downstream: nitrogen retention, protein synthesis, elevated IGF-1 (hepatic and intramuscular), increased RBC output, HPTA suppression.
Pharmacokinetics
Plasma half-life approximately 7 days. Once-weekly pinning produces a measurable peak-to-trough swing; twice-weekly (Mon/Thu split) smooths plasma testosterone to within ~30% of the daily average. Steady-state reached at week 4–5.
Potential Side Effects
Oestrogenic effects from aromatisation (gyno risk, water retention, BP elevation) manageable with anastrozole 0.25–0.5 mg EOD dosed by bloodwork. Androgenic effects (skin, hair) genotype-dependent. HPTA suppression universal — full PCT non-negotiable. HDL typically drops 20–30%.
Cycle & Stacking Guide
Foundation compound: 12–16 weeks at 400–500 mg/week for beginners; add secondary anabolics per goal (deca/anadrol for mass, primobolan/boldenone for lean-gain, trenbolone/masteron for cutting). PCT (Nolva+Clomid) begins 14 days after last injection.
Manufacturer Notes
Pharmtech is an independent producer in the research-compound market. Before first use, request the batch-specific Certificate of Analysis and confirm the vial’s tamper-evident seal is intact.
Storage & Handling
Store upright at 15–25 °C in the original box, protected from light and moisture. Oil-based injectables are shelf-stable for the duration printed on the vial when kept at controlled room temperature. Do not refrigerate — cold thickens the carrier oil and makes drawing/injecting harder. Keep out of reach of children. For research and educational purposes only.
Reviews
There are no reviews yet.